A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed
Do the drugs elotuzumab, polmalidomide, bortezomib or dexamethasone help people with
Basic Study Information
Purpose:Location: University of Rochester
This research study is studying a combination of study drugs as a possible treatment
relapsed and refractory Multiple Myeloma. The interventions involved in this study
elotuzumab, pomalidomide, bortezomib, dexamethasone.
Lead Researcher (Principal Investigator)
Lead Researcher: Brea Lipe
Study Contact InformationStudy Coordinator: Brea C. Lipe, MD
Phone: (585) 275-5823
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search